Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Its a new corporate presentation, which they update quarterly. The new things I saw from the last one:

-for chronic pain, they've identified who they are collaborating with. It's not Cara Therapeutics as I had guessed. It's JT Pharmaceuticals, which is run by McNab, one of their directors.

-Data will be available on chronic pain and the vivitrol "me too" implants in 1H 2018.

-Data on first co-cohort of parkinsons' Phase I/II in 1H 2018 as well.

-Interesting, slide on page 13 is entitled "505(b)(2) regulatory pathway" but does not include Phase III trials, which is confusing. The next conference call I'd like to hear them flesh this out. Are they saying Phase III won't be required?